Task: Answer the multiple choice question.
Question: Which compound exhibits a 17.201\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a: CCNc1nc(NC(C)C)nc(Oc2ccc(=O)n(C)n2)n1
b: CC(C)C(NC(=O)c1ccc(C(C)(C)C)cc1)C(=O)NCc1ccccn1
c: COc1ccc(NC2CC(=O)N(c3cc([N+](=O)[O-])ccc3C)C2=O)cc1
d: Cc1n[nH]c(C)c1CCN(C)C(=O)C1CCC(=O)N(CC2CCCCC2)C1
e: Cc1cccc(NC(=S)N2CCC(N(C)CC3CCCO3)CC2)c1
Answer: a. CCNc1nc(NC(C)C)nc(Oc2ccc(=O)n(C)n2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCNc1nc(NC(C)C)nc(Oc2ccc(=O)n(C)n2)n1
CCNc1nc(NC(C)C)nc(Oc2ccc(=O)n(C)n2)n1
6-[[4-(ethylamino)-6-(propan-2-ylamino)-1,3,5-triazin-2-yl]oxy]-2-methylpyridazin-3-one